Clinical Trial Update: Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial update of a Rebeccamycin Analog in children with relapsed or refractory neuroblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Rebeccamycin analog (rebeccamycin analog)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED